Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity

(2011) Gianni Bussolati et al.   PLoS One

Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature

(2010) Stella Mook et al.   ANNALS OF SURGICAL ONCOLOGY

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer

(2010) Michael Knauer et al.   BREAST CANCER RESEARCH AND TREATMENT

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age

(2009) S. Mook et al.   ANNALS OF ONCOLOGY

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays

(2009) Kathy S. Albain et al.   BREAST

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

(2009) Kathy S Albain et al.   LANCET ONCOLOGY

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

(2008) Stella Mook et al.   BREAST CANCER RESEARCH AND TREATMENT

A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer

(2008) X.-J. Ma et al.   CLINICAL CANCER RESEARCH